Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.
2.

Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.

Childers NK, Miller KL, Tong G, Llarena JC, Greenway T, Ulrich JT, Michalek SM.

Infect Immun. 2000 Oct;68(10):5509-16.

3.

Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant.

Ulrich JT, Cieplak W, Paczkowski NJ, Taylor SM, Sanderson SD.

J Immunol. 2000 May 15;164(10):5492-8.

4.

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration.

Baldridge JR, Yorgensen Y, Ward JR, Ulrich JT.

Vaccine. 2000 May 8;18(22):2416-25.

PMID:
10738099
5.
6.

3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities.

Johnson DA, Keegan DS, Sowell CG, Livesay MT, Johnson CL, Taubner LM, Harris A, Myers KR, Thompson JD, Gustafson GL, Rhodes MJ, Ulrich JT, Ward JR, Yorgensen YM, Cantrell JL, Brookshire VG.

J Med Chem. 1999 Nov 4;42(22):4640-9.

PMID:
10579826
7.

Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs).

Johnson DA, Sowell CG, Johnson CL, Livesay MT, Keegan DS, Rhodes MJ, Ulrich JT, Ward JR, Cantrell JL, Brookshire VG.

Bioorg Med Chem Lett. 1999 Aug 2;9(15):2273-8.

PMID:
10465560
8.

Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A.

Thompson HS, Davies ML, Watts MJ, Mann AE, Holding FP, O'Neill T, Beech JT, Thompson SJ, Leesman GD, Ulrich JT.

Vaccine. 1998 Dec;16(20):1993-9.

PMID:
9796056
9.

Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17.

Zimmerman DH, Ulrich JT, Wright C, Lloyd JP, Winship MD, Sarin PS.

AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):741-9.

PMID:
9643374
10.

HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.

VanCott TC, Kaminski RW, Mascola JR, Kalyanaraman VS, Wassef NM, Alving CR, Ulrich JT, Lowell GH, Birx DL.

J Immunol. 1998 Feb 15;160(4):2000-12.

11.

Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.

VanCott TC, Mascola JR, Kaminski RW, Kalyanaraman V, Hallberg PL, Burnett PR, Ulrich JT, Rechtman DJ, Birx DL.

J Virol. 1997 Jun;71(6):4319-30.

12.

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.

Astiz ME, Rackow EC, Still JG, Howell ST, Cato A, Von Eschen KB, Ulrich JT, Rudbach JA, McMahon G, Vargas R, et al.

Crit Care Med. 1995 Jan;23(1):9-17.

PMID:
8001393
13.

Monophosphoryl lipid A as an adjuvant. Past experiences and new directions.

Ulrich JT, Myers KR.

Pharm Biotechnol. 1995;6:495-524. Review.

PMID:
7551233
14.

Methods of measuring antibodies in sera/plasma, ascites, and tissue-culture media.

Rudbach JA, Cantrell JL, Ulrich JT.

Methods Mol Biol. 1995;45:79-82. No abstract available.

PMID:
7550695
15.
16.

Prophylactic use of monophosphoryl lipid A in patients at risk for sepsis.

Rudbach JA, Myers KR, Rechtman DJ, Ulrich JT.

Prog Clin Biol Res. 1994;388:107-24. Review. No abstract available.

PMID:
7831353
17.

Preparation and characterization of biologically active 6'-O-(6-aminocaproyl)-4'-O-monophosphoryl lipid A and its conjugated derivative.

Myers KR, Ulrich JT, Qureshi N, Takayama K, Wang R, Chen L, Emary WB, Cotter RJ.

Bioconjug Chem. 1992 Nov-Dec;3(6):540-8.

PMID:
1463784
18.

Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL.

Schneerson R, Fattom A, Szu SC, Bryla D, Ulrich JT, Rudbach JA, Schiffman G, Robbins JB.

J Immunol. 1991 Oct 1;147(7):2136-40.

PMID:
1918948
19.

Cross-neutralizing antibodies in rabbits immunized with HIV-1 gp160 purified from simian cells infected with a recombinant vaccinia virus.

Klaniecki J, Dykers T, Travis B, Schmitt R, Wain M, Watson A, Sridhar P, McClure J, Morein B, Ulrich JT, et al.

AIDS Res Hum Retroviruses. 1991 Oct;7(10):791-8.

PMID:
1742074
20.

Bacterial lipopolysaccharide acts synergistically with selected macromolecular polyanions to induce MHC-nonrestricted cytotoxic cells.

Winkler DF, Myers KR, Hochstein HD, Ulrich JT, Wunderlich JR.

Immunobiology. 1991 Jun;182(3-4):216-33.

PMID:
1916877
21.
22.

Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A.

Baker PJ, Haslov KR, Fauntleroy MB, Stashak PW, Myers K, Ulrich JT.

Infect Immun. 1990 Mar;58(3):726-31.

23.

Immunotherapy with bacterial endotoxins.

Rudbach JA, Cantrell JL, Ulrich JT, Mitchell MS.

Adv Exp Med Biol. 1990;256:665-76. Review. No abstract available.

PMID:
2183570
24.

Trehalose dimycolate enhances resistance to infection in neutropenic animals.

Madonna GS, Ledney GD, Elliott TB, Brook I, Ulrich JT, Myers KR, Patchen ML, Walker RI.

Infect Immun. 1989 Aug;57(8):2495-501.

25.

Monoclonal antibodies to bovine UDP-galactosyltransferase. Characterization, cross-reactivity, and utilization as structural probes.

Ulrich JT, Schenck JR, Rittenhouse HG, Shaper NL, Shaper JH.

J Biol Chem. 1986 Jun 15;261(17):7975-81.

26.

Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila.

Miller MF, Martin JR, Johnson P, Ulrich JT, Rdzok EJ, Billing P.

J Infect Dis. 1984 May;149(5):714-8.

PMID:
6726002
27.
28.

Immune interferon induction by T-cell mitogens involves different T-cell subpopulations.

Archer DL, Smith BG, Ulrich JT, Johnson HM.

Cell Immunol. 1979 Dec;48(2):420-6. No abstract available.

PMID:
315836
29.

Effects of chlorpromazine on antibody production in vitro.

Lovett CL, Ulrich JT, Simms BG, Goldstein AL.

Birth Defects Orig Artic Ser. 1978;14(5):407-22. No abstract available.

PMID:
356910
30.

Transient thermal blooming of a slewed laser beam containing a region of stagnant absorber.

Berger PJ, Ulrich PB, Ulrich JT, Gebhardt FG.

Appl Opt. 1977 Feb 1;16(2):345-54. doi: 10.1364/AO.16.000345.

PMID:
20168493
31.
32.

Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.

Goldstein AL, Cohen GH, Rossio JL, Thurman GB, Brown CN, Ulrich JT.

Med Clin North Am. 1976 May;60(3):591-606. No abstract available.

PMID:
131889
33.
34.

Induction and characterization of -galactosidase in an extreme thermophile.

Ulrich JT, McFeters GA, Temple KL.

J Bacteriol. 1972 May;110(2):691-8.

36.

Supplemental Content

Loading ...
Support Center